Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens

Time at home is a critically important outcome to adults with acute myeloid leukemia (AML) when selecting treatment; however, no study to date has adequately described the amount of time older adults spend at home following initiation of chemotherapy. We queried records from a multi-institution heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Christopher E., Heiling, Hilary M., Beke, Konan E., Deal, Allison M., Bryant, Ashley L., Coombs, Lorinda A., Foster, Matthew C., Richardson, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071106/
https://www.ncbi.nlm.nih.gov/pubmed/35861016
http://dx.doi.org/10.3324/haematol.2022.280728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071106/
https://www.ncbi.nlm.nih.gov/pubmed/35861016
http://dx.doi.org/10.3324/haematol.2022.280728

Ejemplares similares